经皮射频消融与微波消融治疗肝细胞癌有效性与安全性比较的Meta分析

鄢金柱; 翁鸿; 张超; 王媛; 杨剑; 彭心宇

doi:10.3969/j.issn.1001-5256.2018.05.020

经皮射频消融与微波消融治疗肝细胞癌有效性与安全性比较的Meta分析

DOI: 10.3969/j.issn.1001-5256.2018.05.020

1. 石河子大学医学院
2. 武汉大学中南医院循证与转化医学中心
3. 十堰市太和医院循证医学中心
4. 石河子大学医学院第一附属医院肝胆外科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2358
- HTML全文浏览量: 50
- PDF下载量: 364
- 被引次数: 0
出版历程
- 收稿日期: 2017-11-02
- 出版日期: 2018-05-20

Clinical effect and safety of percutaneous radiofrequency ablation versus microwave ablation in treatment of hepatocellular carcinoma:a Meta-analysis

Shihezi University School of Medicine

摘要

摘要: 目的通过Meta分析和试验序贯分析系统评价经皮射频消融(RFA)和微波消融(MWA)在肝细胞癌(HCC)中的有效性和安全性。方法计算机检索Pub Med、The Cochrane Library(2017年6期)、EMbase、中国生物医学文献数据库(CBM)和中国知网、维普、万方数据库,搜索有关RFA对比MWA治疗HCC的随机对照试验和队列研究,检索时限均为从建库至2017年6月。由2名评价员独立筛选文献、提取资料和评价纳入研究的质量,采用Rev Man5.3软件进行Meta分析,采用TSAv0.9 Beta软件进行试验序贯分析。结果最终纳入6项RCT和11项回顾性队列研究,共1782例患者。Meta分析结果显示:在总体消融率方面2种消融方法差异无统计学意义[比值比(OR)=0.88,95%可信区间(95%CI):0.63~1.22,P=0.44];在总体局部复发率方面2种消融方法差异无统计学意义(OR=1.20,95%CI:0.90~1.59,P=0.21);在1年总体生存率和3年总体生存率方面2种消融方法差异无统计学意义(OR分别为0.72、1.13,95%CI分别为0.45~1...
- 癌,肝细胞 /
- 导管消融术 /
- Meta分析
Abstract: Objective To investigate the clinical effect and safety of percutaneous radiofrequency ablation ( RFA) versus microwave ablation ( MWA) in the treatment of hepatocellular carcinoma ( HCC) using the meta-analysis and trial sequential analysis ( TSA) . Methods Pub Med, The Cochrane Library ( Issue 6, 2017) , EMbase, CNKI, VIP, CBM, and Wanfang Data were searched for randomized controlled trials ( RCTs) and cohort studies about RFA versus MWA in the treatment HCC published up to June 2017. Two reviewers independently screened the articles, extracted data, and evaluated their quality. Rev Man 5. 3 was used for the meta-analysis, and TSA v0. 9 Beta was used for TSA. Results A total of 6 RCTs and 11 cohort studies were included, with 1782 patients in total. The meta-analysis showed that there were no significant differences between RFA and MWA in complete ablation rate ( odds ratio [OR]= 0. 88, 95% confidence interval [CI]: 0. 63-1. 22, P = 0. 44) , overall local recurrence rate ( OR = 1. 2, 95% CI: 0. 90-1. 59, P = 0. 21) , and 1-and 3-year overall survival rates ( 1-year: OR = 0. 72, 95% CI: 0. 45-1. 14, P = 0. 16; 3-year: OR = 1. 13, 95% CI: 0. 85-1. 50, P = 0. 41) .The subgroup analysis showed that in patients with a tumor diameter of ≤3 cm or 3-5 cm, there were no significant differences in complete ablation rate and local recurrence rate between RFA and MWA, while the MWA group had a significantly shorter ablation time than the RFA group ( MD = 8. 08, 95% CI: 4. 79-11. 37, P < 0. 001) . As for the incidence rate of adverse events, the MWA group had significantly higher incidence rates of liver pain and postoperative pyrexia than the RFA group ( P = 0. 02 and P < 0. 01) . TSA was performed for complete ablation rate, local recurrence rate, and 3-year survival rate, and the results showed that more studies were needed to support this evidence. Conclusion RFA and MWA have a similar clinical effect in the treatment of HCC, and compared with RFA, MWA has a shorter time of operation and a higher incidence rate of complications.
- carcinoma, hepatocellular /
- catheter ablation /
- Meta-analysis

HTML全文

参考文献(37)

[1]BRUIX J, SHERMAN M.Management of hepatocellular carcinoma:an update[J].Hepatology, 2011, 53 (3) :1020-1022.

[2]NISHIKAWA H, KIMURA T, KITA R, et al.Radiofrequency ablation for heatocellular carcinoma[J].Int J Hyerthermia, 2013, 29 (6) :558-568.

[3]SIMON CJ, DUPUY DE, MAYO-SMITH WW.Microwave ablation:principles and applications[J].Radiographics, 2005, 25 (Suppl 1) :s69-s83.

[4]LENCIONI R, CROCETTI L.Local-regional treatment of hepatocellular carcinoma[J].Radiology, 2012, 262 (1) :43-58.

[5]THORLUND K, ENGSTRM J, WETTERSLEV J, et al.User manual for trial sequential analysis (TSA) :Copenhagen Trial Unit.Copenhagen, Denmark:Centre for Clinical Intervention Research[EB/OL].[2017-11-02]http://www.ctu.dk/tsa.

[6]HIGGINS JPT, GREEN S.Cochrane Handbook for Systematic Reviews of Interventions Version5.1.0[EB/OL].[2017-11-02]http://training.cochrane.org/handbook

[7]WELLS GA, SHEA B, O’CONNELL D, et al.The NewcastleOttawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses[EB/OL].[2017-11-02]http://www.ohri.ca/programs/clinical epidemiology/oxford.htm.

[8]SHIBATA T, IIMURO Y, YAMAMOTO Y, et al.Small hepatocellular carcinoma:Comparison of radiofrequency ablation and percutaneous microwave coagulation therapy[J].Radiology, 2002, 223 (2) :331-337.

[9]GU QF, ZHOU DJ, LI YH, et al.Comparison of ultrasoundguided microwave ablation and radiofrequency ablation in the treatment of small hepatocellular carcinoma[J].J Med Theor&Pract, 2010, 23 (6) :683-684. (in Chinese) 古琼芳, 周懂晶, 李益红, 等.超声引导下微波与射频消融治疗小肝癌的临床疗效比较[J].医学理论与实践, 2010, 23 (6) :683-684.

[10]TIAN WS, KUANG M, LYU M, et al.Ultrasound guided percutaneous radiofrequency ablation and microwave ablation for liver tumors:a randomized controlled trial[J].Chin J Hepatobiliary Surg, 2014, 20 (2) :119-122. (in Chinese) 田文硕, 匡铭, 吕明, 等.超声引导经皮射频消融与微波消融治疗肝脏肿瘤的随机对照研究[J].中华肝胆外科杂志, 2014, 20 (2) :119-122.

[11]WANG XG, PAN JR, ZHANG F.Percutaneous radiofrequency ablation and microwave ablation in the treatment of primary hepatocellular carcinoma[J].Chin J Med Imaging, 2015, 23 (8) :606-609. (in Chinese) 王喜功, 潘吉荣, 张峰.超声引导下经皮射频消融与微波消融治疗原发性肝细胞癌的比较[J].中国医学影像学杂志, 2015, 23 (8) :606-609.

[12]XU J, ZHAO Y, FU XD, et al.Comparative analysis of microwave ablation and percutaneous radiofrequency ablation in the treatment of primary hepatocellular carcinoma[J].China Med Equip, 2016, 13 (12) :55-58. (in Chinese) 徐娟, 赵晔, 付晓丹, 等.超声引导下经皮微波消融与射频消融治疗原发性肝癌的临床疗效对比分析[J].中国医学装备, 2016, 13 (12) :55-58.

[13]SHEN Z, YAN H.Comparative analysis of microwave ablation and percutaneous radiofrequency ablation in the treatment of primary hepatocellular carcinoma[J].Mod J Integr Tradit Chin West Med, 2016, 25 (33) :3659-3662. (in Chinese) 沈桢, 阎皓.射频消融与微波消融治疗原发性小肝癌安全性、有效性及免疫功能影响的对比研究[J].现代中西医结合杂志, 2016, 25 (33) :3659-3662.

[14]OHMOTO K, YOSHIOKA N, TOMIYAMA Y, et al.Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas[J].J Gastroenterol Hepatol, 2009, 24 (2) :223-227.

[15]LU MD, XU HX, XIE XY, et al.Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma:a retrospective comparative study[J].J Gastroenterol, 2005, 40 (11) :1054-1060.

[16]DING J, JING X, LIU J, et al.Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma[J].Eur J Radiol, 2013, 82 (9) :1379-1384.

[17]ZHANG L, WANG N, SHEN Q, et al.Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma[J].PLo S One, 2013, 8 (10) :e76119.

[18]ABDELAZIZ AO, NABEEL MM, ELBAZ TM, et al.Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma:prospective analysis[J].Scand J Gastroenterol, 2015, 50 (4) :479-484.

[19]VOGL TJ, FARSHID P, NAGUIB NN, et al.Ablation therapy of hepatocellular carcinoma:A comparative study between radiofrequency and microwave ablation[J].Abdom Imaging, 2015, 40 (6) :1829-1837.

[20]HU P, QIAN GJ, SUN AX, et al.Comparsion the efficacy and safety of radiofrequency ablation and microwave ablation for elderly hepatocellular carcinoma patients[J].J Hepatobiliary Surg, 2012, 20 (5) :348-352. (in Chinese) 胡鹏, 钱国军, 孙爱学, 等.微波和射频治疗高龄肝癌患者疗效和安全性比较[J].肝胆外科杂志, 2012, 20 (5) :348-352.

[21]XU HX, XIE XY, LU MD, et al.Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation[J].Clin Radiol, 2004, 59 (1) :53-61.

[22]YIN XY, XIE XY, LU MD, et al.Percutaneous thermal ablation of medium and large hepatocellular carcinoma:long-term outcome and prognostic factors[J].Cancer, 2009, 115 (9) :1914-1923.

[23]GUO ZY, FU LP, FU ZG, et al.Comparison of efficacy of percutaneous radiofrequency ablation and microwave ablation for liver cancer[J].Pract J Cancer, 2015, 30 (9) :1386-1388. (in Chinese) 郭志远, 付吕平, 付志国, 等.经皮射频消融术与微波消融治疗肝癌的治疗效果对比[J].实用癌症杂志, 2015, 30 (9) :1386-1388.

[24]QIAN GJ, WANG N, SHEN Q, et al.Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma:Experimental and clinical studies[J].Eur Radiol, 2012, 22 (9) :1983-1990.

[25]XU Q, KOBAYASHI S, YE X, et al.Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma:a meta-analysis of 16, 103 patients[J].Sci Rep, 2014, 4 (Suppl) :7252.

[26]QI X, TANG Y, AN D, et al.Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma:a meta-analysis of randomized controlled trials[J].J Clin Gastroenterol, 2014, 48 (5) :450-457.

[27]SUN B, ZHENG CS, FENG GS, et al.Radiofrequency ablation versus surgical resection for small hepatocellular carcinoma:a meta-analysis[J].World Chin J Dig, 2011, 19 (31) :3255-3263. (in Chinese) 孙彪, 郑传胜, 冯敢生, 等.射频消融对比手术切除治疗小肝癌的Meta分析[J].世界华人消化杂志, 2011, 19 (31) :3255-3263.

[28]FENG Q, CHI Y, LIU Y, et al.Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma:a meta-analysis of 23 studies[J].J Cancer Res Clin Oncol, 2015, 141 (1) :1-9.

[29]LI L, ZHANG J, LIU X, et al.Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma:a meta-analysis[J].J Gastroenterol Hepatol, 2012, 27 (1) :51-58.

[30]SEKI T, WAKABAYASHI M, NAKAGAWA T, et al.Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma[J].Cancer, 1994, 74 (3) :817-825.

[31]LI M, YU X, LIANG P, et al.Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder[J].Int J Hyperthermia, 2015, 31 (6) :579-587.

[32]LIVRAGHI T, MELONI F, SOLBIATI L, et al.Collaborative Italian Group using AMICA system.Complications of microwave ablation for liver tumors:Results of a multicenter study[J].Cardiovasc Intervent Radiol, 2012, 35 (4) :868-874.

[33]CHINNARATHA MA, CHUANG MY, FRASER RJ, et al.Percutaneous thermal ablation for primary hepatocellualr carcinoma:a systematic review and meta-analysis[J].J Gastroenterol Hepatol, 2016, 31 (2) :294-301.

[34]FACCIORUSSO A, di MASO M, MUSCATIELLO N.Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma:a systematic review and meta-analysis[J].Int J Hyperthermia, 2016, 32 (3) :339-344.

[35]WANG YB, LIAO JT, LI YY, et al.Comparison of percutaneous microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma:a Meta analysis[J].Chin J Med Imaging Technol, 2014, 30 (12) :1869-1873. (in Chinese) 王译斌, 廖锦堂, 李悦怡, 等.对比经皮微波消融与射频消融治疗肝癌疗效的Meta分析[J].中国医学影像技术, 2014, 30 (12) :1869-1873.

[36]WRIGHT AS, LEE FT, MAHVI DM.Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis[J].Ann Surg Oncol, 2003, 10 (3) :275-283.

[37]LU LG.Advances in early screening and diagnosis of hepatocellular carcinoma[J].J Clin Hepatol, 2017, 33 (7) :1257-1261. (in Chinese) 陆伦根.原发性肝癌的早期筛查及诊断[J].临床肝胆病杂志, 2017, 33 (7) :1257-1261.

施引文献

资源附件(0)

访问统计